Chronic Obstructive Pulmonary Disease Foundation Condemns Big Tobacco Acquisition of Pharmaceutical Company
July 30, 2021
July 30, 2021
WASHINGTON, July 30 -- The Chronic Obstructive Pulmonary Disease Foundation issued the following news release:
Philip Morris International, which markets cigarettes internationally, is purchasing the pharmaceutical company Vectura Group PLC, which develops and manufactures inhalers widely used by patients with Chronic Obstructive Pulmonary Disease (COPD). The COPD Foundation condemns this acquisition. A company that profits from the sale of products that cause COPD should not benefi . . .
Philip Morris International, which markets cigarettes internationally, is purchasing the pharmaceutical company Vectura Group PLC, which develops and manufactures inhalers widely used by patients with Chronic Obstructive Pulmonary Disease (COPD). The COPD Foundation condemns this acquisition. A company that profits from the sale of products that cause COPD should not benefi . . .